Sign in

CIK 0001817229 · <br>Emerging growth company

Vor Biopharma Inc.

Sign in to watch
Ticker
VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
811591163
Phone
617-655-6580
Business address
500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
  1. 3 Insider Initial Statement of Ownership
  2. 4 Grant or award Director acquired 4,625,346 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Returned to the company CFO returned 694,137 shares (to the company)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Director sold 400,408 shares at an average $25.90 ($10,368,938)
  11. 4 Open-market sale Director sold 221,166 shares at an average $28.06 ($6,204,863)
  12. 4 Open-market sale Director sold 117,050 shares at an average $29.34 ($3,433,992)
  13. 4 Open-market sale 10% owner sold 37,533 shares at an average $30.19 ($1,133,103)
  14. 4 Open-market sale 10% owner sold 73,676 shares at an average $31.88 ($2,348,744)
  15. 4 Open-market sale Director sold 464,025 shares at an average $29.54 ($13,707,361)
  16. 4 Open-market sale 10% owner sold 96,657 shares at an average $31.08 ($3,003,706)
  17. 4 Open-market sale 10% owner sold 124,146 shares at an average $33.16 ($4,116,369)
  18. 4 Open-market sale 10% owner sold 98,387 shares at an average $36.12 ($3,553,499)
  19. 4 Open-market sale 10% owner sold 41,752 shares at an average $39.43 ($1,646,237)
  20. 4 Derivatives Options or other derivatives

Page 2 of 11 · 212 filings